Evaluation of the attitude of patients suffering from psychiatric disease and staff personal in psychiatric hospitals regarding clinical studies underlying the German Drug law.

Evaluation of the attitude of patients suffering from psychiatric disease and staff personal in psychiatric hospitals regarding clinical studies underlying the German Drug law. - FEPMSA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009619

Enrollment

320

Registered

2015-11-05

Start date

2017-01-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20 F25 F32 F33

Interventions

Group 1: Patientgroup 1: Patients which are included suffer from depressive disorder (ICD10: F32.*) or recurrent depressive disorder (ICD10: F33.*). Age from 18 to 65 years Patients must stay voluntar

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patientgroup 1: actually treatment in hospital age 18-65 years diagnosis (ICD10): F32 and F33 Patientgroup 2: actually treatment in hospital age 18-65 years diagnosis (ICD10): F20 and F25 medical staff group 1: physicians in psychiatric hospital medical staff group 2: nurses in psychaitric hospital

Exclusion criteria

Exclusion criteria: enforced stay in hospital limited contractual capability

Design outcomes

Primary

Measure	Time frame
The staff personal groups "physicians" and "nurses" are asked to fullfill one-time-only the questionaire. Primary endpoint: Group comparison of the sum score in the questionaire "Attitude of sphysicians and careers to clinical studies underlying the GML".	—

Secondary

Measure	Time frame
Both patientgroups are asked to fullfill one-time-only the questionaires "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML" and the "DAI-10", German version. Hypothesis 2: Groupcomparison of patientgroup 1 and patientgroup 2. Sumscore of the questionaire "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML". Hypothesis 3: Evaluation of the sumscore of the questionaire "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML" and sumscore of the questionaire "DAI-10", German version. - Correlation of both sumscores in patientgroup 1. - Correlation of both sumscores in patientgroup 2.	—

Measure

Time frame

Both patientgroups are asked to fullfill one-time-only the questionaires "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML" and the "DAI-10", German version. Hypothesis 2: Groupcomparison of patientgroup 1 and patientgroup 2. Sumscore of the questionaire "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML". Hypothesis 3: Evaluation of the sumscore of the questionaire "Attitude of patients suffering from psychiatric diseases to clinical studies underlying the GML" and sumscore of the questionaire "DAI-10", German version. - Correlation of both sumscores in patientgroup 1. - Correlation of both sumscores in patientgroup 2.

—

Countries

Germany

Contacts

Public ContactDirk Reske

LVR-Klinik Köln

dirk.reske@lvr.de+49-221-8993797

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026